Fig. 1From: Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancerThe trend of QALYs in patients suffering from recurrent and metastatic head and neck cancer in cohort 1 and cohort 2 at pre-determined intervalsBack to article page